WHO Medical Devices Donations - SPANISH Version - Las tecnologías sanitarias son fundamentales en un sistema de salud operativo. Los dispositivos médicos, en concreto, son cruciales para la prevención, el diagnóstico, el tratamiento y la rehabilitación de enfermedades. Estos documentos están d...irigidos a ingenieros biomédicos, administradores sanitarios,
donantes, organizaciones no gubernamentales e instituciones científicas implicados en la tecnología sanitaria a nivel de distrito, nacional, regional o mundial.
more
Guía de buenas prácticas.Tercera edición
Las directrices se organizan en torno a ocho principios clave que corresponden al curso del contrato de un funcionario. El diagrama adjunto representa los principios de forma visual. Cada principio cuenta con indicadores y comentarios de apoyo, así como ...con estudios de caso diseñados para ayudar al lector a comprender mejor los conceptos en los que se basan los principios y cómo pueden llevarse a la práctica. Los principios e indicadores están pensados para ser aplicados tanto al personal internacional como al nacional y tanto al de oficina como al de campo, reconociendo que puede ser necesario realizar ajustes para tener en cuenta las necesidades y características únicas de cada grupo y de la organización. Constituyen una herramienta de aprendizaje, reflexión y planificación, más que un conjunto de reglas rígidas o soluciones aplicables en todas las condiciones.
more
Este documento pretende ser una herramienta de trabajo que ayude
a comprender las dimensiones de la desnutrición infantil en el mundo, sus causas y consecuencias, pero también y muy especialmente las líneas básicas de intervención en las que trabajamos para luchar contra ella en los contextos ...más difíciles. [UNICEF]
more
LLEVADA A CABO POR LOS AGENTES HUMANITARIOS Y LOS DEFENSORES DE LOS DERECHOS HUMANOS EN LOS CONFLICTOS ARMADOS Y OTRAS SITUACIONES DE VIOLENCIA
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major components and features of effective systems for the tre...atment of drug use disorders. They describe treatment modalities and interventions to match the needs of people at different stages and severities of drug use disorders, in a manner consistent with the treatment of any chronic disease or health condition. The Standards are aspirational, and such, national or local treatment services or systems need not attempt to meet all the standards and recommendations made in this document all at once. However over time, progressive quality improvement, with ‘evidence-based and ethical practice’ as an objective, can and should be expected to achieve better organized, more effective and ethical systems and services for people with drug use disorders.
more
In order to meet changing global population needs and consumer expectations, healthcare systems worldwide are under transformation and face restructuring. As systems adapt and shift their emphasis in response to the disparate requests for healthcare services, oppor-tunities emerge for nurses, especi...ally the APN, to meet these demands and unmet needs (Bryant-Lukosius et al. 2017; Carryer et al. 2018; Cassiani & Zug 2014; Cooper & Docherty 2018; Hill et al. 2017; Maier et al.2017). In 2002, the International Council of Nurses (ICN) pro-vided an official position on Advanced Practice Nursing (ICN 2008a). Since that time, worldwide development has increased significantly and simultaneously this field of nursing has matured. ICN felt that a review of its position was needed to assess the relevance of the definition and characteristics offered in 2002. This guid-ance paper defines diverse elements such as assump-tions and core components of the APN. The attributes and descriptors presented in this paper are intended to promote a common vision to continue to enable a greater understanding by the international nursing and healthcare communities for the development of roles commonly identified as Clinical Nurse Specialist (CNS) and Nurse Practitioner (NP).
more
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...on of several factors related to the parasite, the vector, and the host. Cutaneous leishmaniasis is the form most frequently reported in the Region and nearly 90% of cases present single or multiple localized lesions. Other cutaneous clinical forms, such as disseminated and diffuse cutaneous leishmaniasis, are more difficult to treat and relapses are common. The mucosal form is serious because it can cause disfigurement and severe disability if not diagnosed and treated early on. Visceral leishmaniasis is the most severe form, as it can cause death in up to 90% of untreated people.
more
El manual aborda de una manera sencilla y participativa la salud sexual y reproductiva y las ITS y VIH-SIDA en el contexto de Perú; la doble protección que ofrece el condón masculino y femenino; y la mejora de la provisión de ambos métodos en los servicios de planificación familiar y de ITS y ...VIH-SIDA, con énfasis en la introducción del condón femenino. Con este libro en mano, los y las proveedores de salud podrán atender con confianza a las usuarias y sus parejas ofreciéndoles más opciones de protección sexual.
more
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...erly endemic EU. Using A, F and E, health ministries and their partners have made considerable progress towards achieving this criterion in formerly endemic EUs worldwide. In 2002, an estimated 1517 million people lived in EUs in which EU-wide implementation of the A, F and E components of SAFE were thought to be needed for the purposes of global elimination of trachoma as a public health problem; by June 2021, that number had fallen to 136.2 million, a 91% reduction. Approximately 85% of the 136.2 million people living in EUs needing A, F and E in June 2021 were in WHO’s African Region.
more